These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26386257)

  • 1. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.
    Julian MC; Lee CC; Tiller KE; Rabia LA; Day EK; Schick AJ; Tessier PM
    Protein Eng Des Sel; 2015 Oct; 28(10):339-50. PubMed ID: 26386257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Protein Eng Des Sel; 2012 Oct; 25(10):591-601. PubMed ID: 22843678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide.
    Lee CC; Julian MC; Tiller KE; Meng F; DuConge SE; Akter R; Raleigh DP; Tessier PM
    J Biol Chem; 2016 Feb; 291(6):2858-73. PubMed ID: 26601942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability.
    Julian MC; Li L; Garde S; Wilen R; Tessier PM
    Sci Rep; 2017 Mar; 7():45259. PubMed ID: 28349921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
    Perchiacca JM; Lee CC; Tessier PM
    Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution for the development of conformation-specific affinity reagents using yeast display.
    Weaver-Feldhaus JM; Miller KD; Feldhaus MJ; Siegel RW
    Protein Eng Des Sel; 2005 Nov; 18(11):527-36. PubMed ID: 16186140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature-inspired design and evolution of anti-amyloid antibodies.
    Julian MC; Rabia LA; Desai AA; Arsiwala A; Gerson JE; Paulson HL; Kane RS; Tessier PM
    J Biol Chem; 2019 May; 294(21):8438-8451. PubMed ID: 30918024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of conformation- and sequence-specific antibodies against amyloid β.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis.
    Tiller KE; Chowdhury R; Li T; Ludwig SD; Sen S; Maranas CD; Tessier PM
    Front Immunol; 2017; 8():986. PubMed ID: 28928732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of the large and highly functional synthetic repertoire of human VH and Vκ domain antibodies.
    Ignatovich O; Jespers L; Tomlinson IM; de Wildt RM
    Methods Mol Biol; 2012; 911():39-63. PubMed ID: 22886245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting and purifying autonomous human variable heavy (VH) domains.
    Tonikian R; Sidhu SS
    Methods Mol Biol; 2012; 911():327-53. PubMed ID: 22886261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.
    Colby DW; Garg P; Holden T; Chao G; Webster JM; Messer A; Ingram VM; Wittrup KD
    J Mol Biol; 2004 Sep; 342(3):901-12. PubMed ID: 15342245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
    Baek DS; Kim YS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the complementarity determining regions to the thermal stability of a single-domain antibody.
    Zabetakis D; Anderson GP; Bayya N; Goldman ER
    PLoS One; 2013; 8(10):e77678. PubMed ID: 24143255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human V
    Henry KA; Kim DY; Kandalaft H; Lowden MJ; Yang Q; Schrag JD; Hussack G; MacKenzie CR; Tanha J
    Front Immunol; 2017; 8():1759. PubMed ID: 29375542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evolution of single-chain antibodies using mRNA display.
    Fukuda I; Kojoh K; Tabata N; Doi N; Takashima H; Miyamoto-Sato E; Yanagawa H
    Nucleic Acids Res; 2006; 34(19):e127. PubMed ID: 17012279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.